Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Benzamide, n-hydroxy-3-[1-[(phenylthio)methyl]-1h-1,2,3-triazol-4-yl]- | 1316652-41-1 | MFCD21363002 | 99.3% | 326.37 g/mol | C16H14N4O2S | 10 MG
SDP

Supplier:  Medchemexpress LLC HY11734810MG

Encompass_Preferred

NCC-149 is a selective histone deacetylase 8 (HDAC8) inhibitor used in neural differentiation research. It is a small-molecule benzamide derivative (C16H14N4O2S; MW 326.37 g/mol; CAS 1316652-41-1) supplied as a solid with documented purity and batch COA.

  • Selective HDAC8 inhibitor useful for neural differentiation studies.
  • Batch-specific purity reported at 99.3% (COA).
  • Available as a small 10 MG solid suitable for research-scale experiments.
  • Solid stable at -20°C for up to 3 years; solvent solutions require colder storage.
  • Comes with COA, SDS, and product datasheet for quality and safety information.

Catalog No. 50-002-27030


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.